ThePeptideGuide.uk LogoNavigation

Educational purposes only. Not medical advice. Consult healthcare professionals before use.

Healing & Recovery
Preclinical

Gonadorelin

Gonadorelin

Also known as: GnRH, LHRH, Factrel, Lutrelef, Gonadorelin Hydrochloride

Overview

Key Facts

Primary Goal: Research and therapeutic applications of Gonadorelin

Binds GnRH receptors (GnRHR) on anterior pituitary gonadotrophs to stimulate LH and FSH secretion. Pulsatile administration mimics endogenous GnRH pulse generator, maintaining receptor sensitivity.

Dosing Information

Half-Life

2-4 minutes (IV); ~10-40 minutes (SC)

Typical Dose

50–200 mcg

Frequency

2-3 times per week (pulsatile protocols vary)

Cycle Length

4-12 weeks in hormone optimization protocols

Administration Routes:
subcutaneousintravenous

Benefits

  • Stimulates endogenous LH and FSH release
  • Supports natural testosterone production without exogenous hormones
  • Used diagnostically to assess pituitary gonadotroph function
  • May help maintain fertility during TRT or post-cycle recovery
  • Preserves natural HPG axis signaling

Side Effects

Injection site reactionsmild
Headachemild
Nauseamild
Abdominal discomfortmild
Flushingmild

Mechanism of Action

1

Binds GnRH receptors (GnRHR) on anterior pituitary gonadotrophs to stimulate LH and FSH secretion

2

Pulsatile administration mimics endogenous GnRH pulse generator, maintaining receptor sensitivity

3

Continuous administration (non-pulsatile) causes receptor downregulation and gonadotropin suppression

Contraindications

Do not use this peptide if any of the following apply:

  • Hormone-dependent malignancies
  • Pregnancy or breastfeeding
  • Known hypersensitivity to GnRH or analogs

Storage & Reconstitution

Unreconstituted (Powder)

Temperature2–8°C (36–46°F)
DurationUp to 3 months

Reconstituted (Mixed)

Temperature2–8°C (36–46°F)
Duration2-4 weeks

Research Summary

Preclinical

Gonadorelin was FDA-approved under the brand names Factrel (for diagnostic use) and Lutrepulse (for pulsatile therapeutic use in hypothalamic amenorrhea). It is the gold-standard diagnostic agent for assessing pituitary GnRH responsiveness. In research and clinical practise, pulsatile gonadorelin has been used to restore fertility in patients with hypothalamic hypogonadism. It has gained renewed interest in the peptide community for maintaining endogenous hormone production alongside testosterone replacement therapy.

Frequently Asked Questions

Common questions about Gonadorelin

UK-Specific Information

Exclusive data points and guidance for UK residents using Gonadorelin

UK Lab Testing

UK Lab Testing

Recommended labs: Medichecks, Thriva (£89-£149 for peptide safety panel)

Why this matters: UK-specific lab testing guidance not available on US competitor sites

Commonly Stacked With

Share on TikTok

Generate a trackable link to share this peptide information on TikTok